animal model, various vaccines targeting beta amyloid (Aβ) have progressed to human clinical trials, with mixed results. More recently, AD vaccines based on tau protein have advanced into clinical testing
nanoparticles surface was optimized to elicit a strong immune response in mouse models. Infection with Group A Streptococci (GAS), one of the most common and widespread human pathogens, can result ... terminal and…
Protein-based subunit vaccines against cancer and infections are attractive because of their safety as well as rapid, cost-effective, and large-scale production. However, they are weekly immunogenic ... subunit-based…
like particle (VLP) platform based on alphavirus VLP (i-αVLP), presenting the malaria circumsporozoite protein (CSP) domain. The proprietary i-αVLP contains antigen insertions into two different sites ... αVLP-based…
strategy to combat different pathogenic bacteria, therefore, we investigated a capsular polysaccharide biosynthesis CapD protein in E. faecium contains 336 amino acids and had putative function for N-linked…
around the forming spore to originate the three-layered structure of the coat. Coat proteins (CotB, CotC, CotG, CotZ and CgeA) have been so far utilized to display heterologous antigens ... vivo model to study H. pylori…
Part of the T3SS forms an extracellular needle and syringe necessary to inject effector proteins in the host cell, subverting normal cellular functions and causing enteric infections. PrgI and SipD ... oral route, alone…
melanoma tumor cell line B16 bearing the OVA protein (B16-OVA) in vivo. In a B16-OVA melanoma tumor challenge model, OT-1-Encap-C vaccination significantly suppressed tumor growth
Tuberculosis continue being an alarming disease that claim thousands of death each year. The protein and lipid antigens components of M. tuberculosis have been motif of interest to create ... smegmatis and M. bovis BCG…
size was assessed in a mouse model using Respiratory Syncytial Virus Fusion protein (RSV-F) as a model antigen. Temperature dependent phase separation appeared to be the most common route
Currently, there is no preventative vaccine for this disease, but some model vaccines are in development. The NS1 protein genes from three isolates of Dengue virus (DENV
engineered devoid of these immunomodulatory domains. The immune responses of recombinant epitope protein was tested in mice models and was found to be more compared to ALT-2. There
immune response in children below 2 years of age. Conjugate vaccines due to their protein component induce a T-cell dependent immune response characterized by enhanced immunogenicity in all ages ... conjugates…
contribute to the research of DNA double-strand break (DSB) repair and propose a model of the relationship between the higher-order chromatin structure, DSB induction, repair, and formation ... Today, in the era of…
specific substrate of cGMPdependent protein kinase). It is a potent inhibitor of protein phosphatase 2A (PP2A) when phosphorylated on two threonines. Dopaminergic neurons of the substantia nigra, which express…
only on the different model systems for stroke research and target gene identification, but also will deal with the difficulties to identify valid target proteins. Many highly impressive findings ... Thus, careful…
believed that this is mostly due to the poor predictivity of current animal based models. Thus there is an urgent need to development of human in vitro systems that ... pathway. PTX not only complimented TCX, but could…
pluripotent cells into neurons and blocking this upregulation prevented neuronal differentiation in several model systems. On the other hand, its forced overexpression led to enhanced neuronal differentiation…
individual subunits or a fusion of the two subunits. The genes for each these proteins are encoded on two separate virulence plasmids; one of the plasmids is specific ... will present studies to demonstrate the efficacy…
latent phases. To address this, vaccine candidates have been designed to include proteins from both phases. Here we review the history of EBV vaccine development and the current strategies ... malignancies…
human health in todayâ??s world. Passive immunotherapies using monoclonal antibodies (mAb) targeting endogenous proteins have fundamentally improved the treatment of NCDs. However, mAb face functional limitations in…
Pneumococcal proteins have been studied as alternative to polysaccharide based vaccines. PspA is one of the most promising vaccine candidates. Several studies showed protection after immunization with ... terminal…
murine challenge model to employ significantly higher challenge dose, we could achieve level of protection with a HerpeVac like vaccine consisting of recombinant soluble gD protein formulated in an AS04 ... vaccine that…
vitro and in vivo, a potent anti-metastatic effect on EGFR+ Lewis lung carcinoma model, while associated side effects were absent. The Her1-ECD is a glycoprotein with a molecular ... purified using immunoaffinity…
For authors and organisers
Publish, present and keep up with your field
Find the right journal for your paper and submit your manuscript.